Association between homocysteine and neopterin in healthy subjects measured by a simple HPLC-fluorometric method

被引:33
作者
Turgan, N [1 ]
Habif, S [1 ]
Parildar, Z [1 ]
Özmen, D [1 ]
Mutaf, I [1 ]
Erdener, D [1 ]
Bayindir, O [1 ]
机构
[1] Ege Univ, Sch Med, Dept Clin Biochem, Izmir, Turkey
关键词
neopterin; homocysteine; reversed-phase chromatography; immunologic marker; cell-mediated immunity;
D O I
10.1016/S0009-9120(01)00226-0
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: Neopterin and homocysteine promote vascular smooth muscle cell proliferation through the activation of nuclear factor, B. The aim of this study was to investigate the relation between these two compounds in healthy subjects by a rapid HPLC-fluorometric method which simplifies sample pretreatment for the measurement of neopterin in serum. Design and methods: In 40 healthy subjects (45.9 +/- 2.1 yr, mean +/- SEM, 10 males, 30 females) serum neopterin concentrations were measured by HPLC- fluorometry and enzyme-linked immunusorbant assay-ELISA and the results were compared. Urinary neopterin and plasma total homocysteine concentrations were assayed by HPLC-fluorometry. Results: Serum neopterin concentrations measured by HPLC and ELISA were 7.5 +/- 0.4 and 7.4 +/- 0.3 nmol/L, respectively, r = 0.92, p < 0.01. Urinary neopterin level was 163.9 +/- 11.0 nmol/mmol creatinine and plasma total homocysteine 7.6 +/- 0.4 mu mol/L. A significant positive correlation was observed between serum neopterin and plasma total homocysteine (r = 0.59, p < 0.01). Conclusions: A simple and rapid sample pretreatment for the measurement of neopterin in serum has been introduced. The significant positive correlation between neopterin and homocysteine implies that, interference with leukocyte function might be a new possible mechanism for the deleterious effects of homocysteine on vascular function. <(c)> 2001 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:271 / 275
页数:5
相关论文
共 29 条
[1]   Homocyst(e)ine, atherosclerosis, and thrombosis [J].
Alpert, MA .
SOUTHERN MEDICAL JOURNAL, 1999, 92 (09) :858-865
[2]   Dihydropteridine reductase activity and neopterin levels in leukemias and lymphomas: is there any correlation between these two parameters? [J].
Altindag, ZZ ;
Sahin, G ;
Isimer, A ;
Akpek, G ;
Kansu, E .
LEUKEMIA & LYMPHOMA, 1999, 35 (3-4) :367-374
[3]   Highly active antiretroviral therapy (HAART) and circulating markers of immune activation: Specific effect of HAART on neopterin [J].
Amirayan-Chevillard, N ;
Tissot-Dupont, H ;
Obadia, Y ;
Gallais, H ;
Mege, JL ;
Capo, C .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (05) :832-834
[4]   Chronic immune stimulation, oxidative stress, and apoptosis in HIV infection [J].
BaierBitterlich, G ;
Fuchs, D ;
Wachter, H .
BIOCHEMICAL PHARMACOLOGY, 1997, 53 (06) :755-763
[5]  
Birk D, 1999, Eur J Med Res, V4, P156
[6]   Simple dipstick assay for semi-quantitative detection of neopterin in sera [J].
Bührer-Sekula, S ;
Hamerlinck, FFV ;
Out, TA ;
Bordewijk, LG ;
Klatser, PR .
JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 238 (1-2) :55-58
[7]   Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia - An effect reversible with vitamin C therapy [J].
Chambers, JC ;
McGregor, A ;
Jean-Marie, J ;
Obeid, OA ;
Kooner, JS .
CIRCULATION, 1999, 99 (09) :1156-1160
[8]   Increased serum neopterin: a marker of coronary artery disease activity in women [J].
Garcia-Moll, X ;
Cole, D ;
Zouridakis, E ;
Kaski, JC .
HEART, 2000, 83 (03) :346-350
[9]   Serum neopterin and complex stenosis morphology in patients with unstable angina [J].
Garcia-Moll, X ;
Coccolo, F ;
Cole, D ;
Kaski, JC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (04) :956-962
[10]   Neopterin: a review [J].
Hamerlinck, FFV .
EXPERIMENTAL DERMATOLOGY, 1999, 8 (03) :167-176